Improving shingles vaccination for veterans on immune-suppressing drugs
Part of Immune system & allergy clinical trials.
This trial tests a way to help doctors encourage more veterans to get the Shingrix vaccine, which protects against shingles. It focuses on veterans taking medications that weaken the immune system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be a clinician working at a VA medical center.
- You need access to the VA's electronic health record system.
- You treat veterans who are on medications that lower immunity.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the shingles vaccine works in people with autoimmune inflammatory diseases. Researchers want to make sure the vaccine provides good protection for patients whose immune systems are affected by their condition or treatment.
This study tests a new shingles vaccine in people with psoriasis or myelofibrosis, some of whom take immune-modifying medications. Researchers want to understand how well the vaccine works and how the immune system responds in these groups.
This trial tests a new shingles vaccine in healthy adults aged 50 to 65. Shingles can cause a painful rash, and the vaccine aims to prevent it.
This Phase 1/2 study tests how safe and how well a shingles (varicella zoster) vaccine works in adults living with HIV whose immune status is measured by CD4 count, plus a healthy comparison group. It may help researchers understand whether the vaccine can safely boost protection in people with HIV.
This study tests a new vaccine to prevent shingles (a painful rash condition) in adults 50 and older. It checks how safe the vaccine is and how well it triggers the body's immune defense.
This study offers the Shingrix shingles vaccine for free to adults with inflammatory rheumatic diseases. It compares how well the vaccine works in people taking immune-suppressing drugs versus those not taking them.
Hear when a new Immunosuppresion trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.